APOE and Alzheimer disease: The AD genetic risk variant, ApoE ɛ4 is considered an important genetically linked biomarker for AD pathophysiology as it correlates with enhanced amyloid plaque formation (Drzezga et al., 2009), and in humans it has been found associated with an increased immune response (Gale et al., 2014).